CeraPedics, Inc   Report issue

For profit Phase 3
Founded: Westminster CO United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2006
NCT00310440
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

CeraPedics, Inc

Active Ingredients

Drugs in Phase 3 Trials (1)

i-factor (1 trial)

Drugs in Other Trials (1)

autologous bone graft (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Constriction, Pathologic (Phase 3)

Spinal Stenosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2